Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-cataract inflammatory reaction with topical steroid and NSAID combination therapy
NL-OMON37669Phase 4Active, not recruiting
- Sponsor
- Het Oogziekenhuis Rotterdam
- Start
- May 2012
- Countries
- 1
01
Overview
Phase 4, single-arm trial in ocular inflammation, sponsored by Het Oogziekenhuis Rotterdam. Primary endpoint: Flare counts. Started May 2012; status: active, not recruiting.
02
Conditions
ocular inflammation
Beyond the preview
Go deeper on NL-OMON37669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37669.